(Q38261287)

1 September 2017

1 reference

title

Translational models of lung disease (English)

1 reference

1 September 2017

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25328010%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

author name string

Paul F Mercer

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25328010%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Katharine Abbott-Banner

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25328010%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Richard G Knowles

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25328010%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

language of work or name

English

0 references

publication date

1 February 2015

1 reference

1 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25328010%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

volume

128

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25328010%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25328010%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

page(s)

235-256

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25328010%20AND%20SRC:MED&resulttype=core&format=json

Animal models of asthma: value, limitations and opportunities for alternative approaches

6 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1042%2FCS20140373

Animal models of asthma: reprise or reboot?

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140373

Mouse models of allergic asthma: acute and chronic allergen challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140373

Moving towards a new generation of animal models for asthma and COPD with improved clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140373

GW274150 and GW273629 are potent and highly selective inhibitors of inducible nitric oxide synthase in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140373

A comparison of antiasthma drugs between acute and chronic ovalbumin-challenged guinea-pig models of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140373

Longitudinal characterization of a model of chronic allergic lung inflammation in mice using imaging, functional and immunological methods.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140373

Efficacy of anti-interleukin-5 therapy with mepolizumab in patients with asthma: a meta-analysis of randomized placebo-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140373

Beta 1-adrenoceptors mediate smooth muscle relaxation in mouse isolated trachea

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140373

Mast cell mediators cause early allergic bronchoconstriction in guinea-pigs in vivo: a model of relevance to asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140373

Airway hyper-responsiveness in lipopolysaccharide-challenged common marmosets (Callithrix jacchus)

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140373

Everything prevents emphysema: are animal models of cigarette smoke-induced chronic obstructive pulmonary disease any use?

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140373

The role of animal models in the pharmacological evaluation of emerging anti-inflammatory agents for the treatment of COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140373

Second hand smoke and COPD: lessons from animal studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140373

Models of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140373

The composition of cigarette smoke determines inflammatory cell recruitment to the lung in COPD mouse models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140373

Animal models of human disease: challenges in enabling translation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140373

Recent advances in pre-clinical mouse models of COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140373

Animal models of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140373

Animal models of COPD: Barriers, successes, and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140373

Cigarette smoke-induced inflammation and respiratory host defense: Insights from animal models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140373

Genetically manipulated mouse models of lung disease: potential and pitfalls

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140373

Testing drugs in animal models of cigarette smoke-induced chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140373

Interleukin-6 neutralization alleviates pulmonary inflammation in mice exposed to cigarette smoke and poly(I:C).

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140373

Using guinea pigs in studies relevant to asthma and COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140373

A new short-term mouse model of chronic obstructive pulmonary disease identifies a role for mast cell tryptase in pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140373

Effects of N-acetylcysteine in ozone-induced chronic obstructive pulmonary disease model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140373

Elastase-induced pulmonary emphysema: insights from experimental models

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140373

Airway disease: the use of large animal models for drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140373

Modeling of asthma, COPD and cystic fibrosis in sheep

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140373

Canine models of asthma and COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140373

Cigarette smoking in rhesus monkeys.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140373

Genomic responses in mouse models poorly mimic human inflammatory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140373

Predicting drug efficacy using integrative models for chronic respiratory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140373

Novel therapeutic approaches for pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140373

Idiopathic pulmonary fibrosis: an epithelial/fibroblastic cross-talk disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140373

Idiopathic pulmonary fibrosis: aberrant recapitulation of developmental programs?

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140373

Molecular targets in pulmonary fibrosis: the myofibroblast in focus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140373

The myofibroblast matrix: implications for tissue repair and fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140373

The bleomycin animal model: a useful tool to investigate treatment options for idiopathic pulmonary fibrosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140373

Animal models of fibrotic lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140373

Murine models of pulmonary fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140373

Adenovector-mediated gene transfer of active transforming growth factor-beta1 induces prolonged severe fibrosis in rat lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140373

Transient expression of IL-1beta induces acute lung injury and chronic repair leading to pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140373

Transfer of tumor necrosis factor-alpha to rat lung induces severe pulmonary inflammation and patchy interstitial fibrogenesis with induction of transforming growth factor-beta1 and myofibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140373

Early growth response gene 1-mediated apoptosis is essential for transforming growth factor beta1-induced pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140373

Genomic profile of matrix and vasculature remodeling in TGF-alpha induced pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140373

Respiratory epithelial cell expression of human transforming growth factor-alpha induces lung fibrosis in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140373

Interleukin-13 induces tissue fibrosis by selectively stimulating and activating transforming growth factor beta(1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140373

Therapeutic targeting of CC ligand 21 or CC chemokine receptor 7 abrogates pulmonary fibrosis induced by the adoptive transfer of human pulmonary fibroblasts to immunodeficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140373

TLR9 differentiates rapidly from slowly progressing forms of idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140373

Targeted injury of type II alveolar epithelial cells induces pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140373

Animal models of acute lung injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140373

Repetitive intratracheal bleomycin models several features of idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140373

Comparison between conventional and "clinical" assessment of experimental lung fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140373

Bleomycin-induced lung injury in mice investigated by MRI: model assessment for target analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140373

Serial micro-CT assessment of the therapeutic effects of rosiglitazone in a bleomycin-induced lung fibrosis mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140373

Semiquantitative measurement of murine bleomycin-induced lung fibrosis in in vivo and postmortem conditions using microcomputed tomography: correlation with pathologic scores--initial results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140373

Pirfenidone attenuates expression of HSP47 in murine bleomycin-induced pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140373

Inhibition of PDGF, VEGF and FGF signalling attenuates fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140373

Imatinib as a novel antifibrotic agent in bleomycin-induced pulmonary fibrosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140373

Pharmacologic differentiation of inflammation and fibrosis in the rat bleomycin model

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140373

γ-Herpes virus-68, but not Pseudomonas aeruginosa or influenza A (H1N1), exacerbates established murine lung fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140373

Age and sex dimorphisms contribute to the severity of bleomycin-induced lung injury and fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140373

Predisposition for disrepair in the aged lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140373

Bacterial infection in chronic obstructive pulmonary disease in 2000: a state-of-the-art review

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140373

Detection of respiratory syncytial virus in adults with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140373

Human metapneumovirus: a ubiquitous and long-standing respiratory pathogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140373

Respiratory viruses in exacerbations of chronic obstructive pulmonary disease requiring hospitalisation: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140373

The role of viruses in acute exacerbations of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140373

Development of a mouse model mimicking key aspects of a viral asthma exacerbation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140373

Human parainfluenza type 3 virus impairs the efficacy of glucocorticoids to limit allergy-induced pulmonary inflammation in guinea-pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140373

Differences in respiratory syncytial virus and influenza infection in a house-dust-mite-induced asthma mouse model: consequences for steroid sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140373

No exacerbation but impaired anti-viral mechanisms in a rhinovirus-chronic allergic asthma mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140373

Cigarette smoke worsens lung inflammation and impairs resolution of influenza infection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140373

Treating viral exacerbations of chronic obstructive pulmonary disease: insights from a mouse model of cigarette smoke and H1N1 influenza infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140373

What can in vitro models of COPD tell us?

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140373

Models and approaches to understand the role of airway remodelling in disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140373

Airway hyperresponsiveness in asthma: lessons from in vitro model systems and animal models

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140373

Acellular normal and fibrotic human lung matrices as a culture system for in vitro investigation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140373

Precision cut lung slices as an efficient tool for in vitro lung physio-pharmacotoxicology studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140373

Exploring lung physiology in health and disease with lung slices

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140373

Application of 'omics technologies to biomarker discovery in inflammatory lung diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140373

Evaluation of fibrosis in precision-cut tissue slices

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140373

In vitro pharmacological characterization of vilanterol, a novel long-acting β2-adrenoceptor agonist with 24-hour duration of action.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140373

Anti-inflammatory modulation of chronic airway inflammation in the murine house dust mite model

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140373

Repeated instillations of Dermatophagoides farinae into the airways can induce Th2-dependent airway hyperresponsiveness, eosinophilia and remodeling in mice: effect of intratracheal treatment of fluticasone propionate

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140373

Whole animal experiments should be more like human randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140373

Reporting in randomized clinical trials improved after adoption of the CONSORT statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140373

Threats to validity in the design and conduct of preclinical efficacy studies: a systematic review of guidelines for in vivo animal experiments

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140373

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140373

Selective Inducible Nitric Oxide Synthase Inhibition Has No Effect on Allergen Challenge in Asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140373

Infections and Airway Inflammation in Chronic Obstructive Pulmonary Disease Severe Exacerbations

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140373

2nd cross company respiratory symposium

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140373

21 January 2018

Identifiers

DOI

10.1042/CS20140373

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25328010%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

1 reference